Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2024-07-01
2025-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Which device requires the shortest time required to achieve a successful ventilation?
2. What is the first attempt success rate of the studied devices?
3. Which device is the easiest to use and the most user-friendly? Study participants will evaluate four different supraglottic devices in a restricted access to the entrapped trauma patient's airway. The maximum number of insertion attempts is limited to three per device.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Crossover Study of the LMA SupremeTM vs Ambu-Aura GainTM
NCT02458794
Tracheal Intubation With Collar Immobilisation : a Comparison of Glidescope and Fastrach
NCT02245880
Evaluation of Airway Adjuncts for Intubation in Entrapped Patients With Difficult Airway Access
NCT06609499
Insertion of Different Supraglottic Airway Devices on Manikin
NCT05523752
Ambu AuraGain vs LMA Supreme in Laparoscopic Surgery
NCT02511652
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LMA Supreme Group
Paramedics using the LMA Supreme airway device
LMA Supreme
The device is inserted and the manikin ventilated
Other Supraglottic Airway Group
Paramedics using other supraglottic devices
SLIPA
The device is inserted and the manikin ventilated
I-gel
The device is inserted and the manikin ventilated
AuraGain
The device is inserted and the manikin ventilated
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LMA Supreme
The device is inserted and the manikin ventilated
SLIPA
The device is inserted and the manikin ventilated
I-gel
The device is inserted and the manikin ventilated
AuraGain
The device is inserted and the manikin ventilated
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* at least four years of practice after finishing paramedic training
* active (working) paramedics
Exclusion Criteria
* retired paramedics
* lack of written informed consent
25 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Uniwersytet Radomski im. Kazimierza Pułaskiego
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dawid J Aleksandrowicz, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Radom
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Radom
Radom, Masovian Voivodeship, Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3/2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.